174 related articles for article (PubMed ID: 26498689)
1. Key contribution of eIF4H-mediated translational control in tumor promotion.
Vaysse C; Philippe C; Martineau Y; Quelen C; Hieblot C; Renaud C; Nicaise Y; Desquesnes A; Pannese M; Filleron T; Escourrou G; Lawson M; Rintoul RC; Delisle MB; Pyronnet S; Brousset P; Prats H; Touriol C
Oncotarget; 2015 Nov; 6(37):39924-40. PubMed ID: 26498689
[TBL] [Abstract][Full Text] [Related]
2. An alternative splicing isoform of eukaryotic initiation factor 4H promotes tumorigenesis in vivo and is a potential therapeutic target for human cancer.
Wu D; Matsushita K; Matsubara H; Nomura F; Tomonaga T
Int J Cancer; 2011 Mar; 128(5):1018-30. PubMed ID: 20473909
[TBL] [Abstract][Full Text] [Related]
3. RNA interference influenced the proliferation and invasion of XWLC-05 lung cancer cells through inhibiting aquaporin 3.
Xiong G; Chen X; Zhang Q; Fang Y; Chen W; Li C; Zhang J
Biochem Biophys Res Commun; 2017 Apr; 485(3):627-634. PubMed ID: 28189680
[TBL] [Abstract][Full Text] [Related]
4. RNA binding motif protein 10 suppresses lung cancer progression by controlling alternative splicing of eukaryotic translation initiation factor 4H.
Zhang S; Bao Y; Shen X; Pan Y; Sun Y; Xiao M; Chen K; Wei H; Zuo J; Saffen D; Zong WX; Sun Y; Wang Z; Wang Y
EBioMedicine; 2020 Nov; 61():103067. PubMed ID: 33130397
[TBL] [Abstract][Full Text] [Related]
5. The Long Noncoding RNA MEG3 Contributes to Cisplatin Resistance of Human Lung Adenocarcinoma.
Liu J; Wan L; Lu K; Sun M; Pan X; Zhang P; Lu B; Liu G; Wang Z
PLoS One; 2015; 10(5):e0114586. PubMed ID: 25992654
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of miR-519d in lung adenocarcinoma inhibits cell proliferation and invasion via the association of eIF4H.
Bai Y; Lu C; Zhang G; Hou Y; Guo Y; Zhou H; Ma X; Zhao G
Tumour Biol; 2017 Mar; 39(3):1010428317694566. PubMed ID: 28351305
[TBL] [Abstract][Full Text] [Related]
7. Nrf2 knockdown by shRNA inhibits tumor growth and increases efficacy of chemotherapy in cervical cancer.
Ma X; Zhang J; Liu S; Huang Y; Chen B; Wang D
Cancer Chemother Pharmacol; 2012 Feb; 69(2):485-94. PubMed ID: 21842204
[TBL] [Abstract][Full Text] [Related]
8. Systemic delivery of siRNA specific to tumor mediated by atelocollagen: combined therapy using siRNA targeting Bcl-xL and cisplatin against prostate cancer.
Mu P; Nagahara S; Makita N; Tarumi Y; Kadomatsu K; Takei Y
Int J Cancer; 2009 Dec; 125(12):2978-90. PubMed ID: 19422046
[TBL] [Abstract][Full Text] [Related]
9. mRNA decay during herpes simplex virus (HSV) infections: protein-protein interactions involving the HSV virion host shutoff protein and translation factors eIF4H and eIF4A.
Feng P; Everly DN; Read GS
J Virol; 2005 Aug; 79(15):9651-64. PubMed ID: 16014927
[TBL] [Abstract][Full Text] [Related]
10. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.
Feng Y; Hu J; Ma J; Feng K; Zhang X; Yang S; Wang W; Zhang J; Zhang Y
Eur J Cancer; 2011 Oct; 47(15):2353-63. PubMed ID: 21680174
[TBL] [Abstract][Full Text] [Related]
11. A Novel Combination RNAi toward Warburg Effect by Replacement with miR-145 and Silencing of PTBP1 Induces Apoptotic Cell Death in Bladder Cancer Cells.
Takai T; Yoshikawa Y; Inamoto T; Minami K; Taniguchi K; Sugito N; Kuranaga Y; Shinohara H; Kumazaki M; Tsujino T; Takahara K; Ito Y; Akao Y; Azuma H
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28106737
[TBL] [Abstract][Full Text] [Related]
12. Expression analysis of Cdc42 in lung cancer and modulation of its expression by curcumin in lung cancer cell lines.
Chen QY; Jiao DM; Yao QH; Yan J; Song J; Chen FY; Lu GH; Zhou JY
Int J Oncol; 2012 May; 40(5):1561-8. PubMed ID: 22266952
[TBL] [Abstract][Full Text] [Related]
13. The synergistic therapeutic effect of cisplatin with Human papillomavirus E6/E7 short interfering RNA on cervical cancer cell lines in vitro and in vivo.
Jung HS; Erkin OC; Kwon MJ; Kim SH; Jung JI; Oh YK; Her SW; Ju W; Choi YL; Song SY; Kim JK; Kim YD; Shim GY; Shin YK
Int J Cancer; 2012 Apr; 130(8):1925-36. PubMed ID: 21630254
[TBL] [Abstract][Full Text] [Related]
14. Reciprocal activation between PLK1 and Stat3 contributes to survival and proliferation of esophageal cancer cells.
Zhang Y; Du XL; Wang CJ; Lin DC; Ruan X; Feng YB; Huo YQ; Peng H; Cui JL; Zhang TT; Wang YQ; Zhang H; Zhan QM; Wang MR
Gastroenterology; 2012 Mar; 142(3):521-530.e3. PubMed ID: 22108192
[TBL] [Abstract][Full Text] [Related]
15. Silencing survivin expression inhibits the tumor growth of non-small-cell lung cancer cells in vitro and in vivo.
Zhang K; Li Y; Liu W; Gao X; Zhang K
Mol Med Rep; 2015 Jan; 11(1):639-44. PubMed ID: 25333812
[TBL] [Abstract][Full Text] [Related]
16. VEGF-C mediates RhoGDI2-induced gastric cancer cell metastasis and cisplatin resistance.
Cho HJ; Kim IK; Park SM; Baek KE; Nam IK; Park SH; Ryu KJ; Choi J; Ryu J; Hong SC; Jeong SH; Lee YJ; Ko GH; Kim J; Won Lee C; Soo Kang S; Yoo J
Int J Cancer; 2014 Oct; 135(7):1553-63. PubMed ID: 24585459
[TBL] [Abstract][Full Text] [Related]
17. A novel herbal formula induces cell cycle arrest and apoptosis in association with suppressing the PI3K/AKT pathway in human lung cancer A549 cells.
Xiong F; Jiang M; Huang Z; Chen M; Chen K; Zhou J; Yin L; Tang Y; Wang M; Ye L; Zhan Z; Duan J; Fu H; Zhang X
Integr Cancer Ther; 2014 Mar; 13(2):152-60. PubMed ID: 24105357
[TBL] [Abstract][Full Text] [Related]
18. Diallyl trisulfide induces apoptosis and inhibits proliferation of A549 cells in vitro and in vivo.
Li W; Tian H; Li L; Li S; Yue W; Chen Z; Qi L; Hu W; Zhu Y; Hao B; Gao C; Si L; Gao F
Acta Biochim Biophys Sin (Shanghai); 2012 Jul; 44(7):577-83. PubMed ID: 22595511
[TBL] [Abstract][Full Text] [Related]
19. [shRNA-mediated insulin-like growth factor I receptor gene silencing inhibits cell proliferation, induces cell apoptosis, and suppresses tumor growth in non-small cell lung cancer: in vitro and in vivo experiments].
Dong AQ; Kong MJ; Ma ZY; Qian JF; Fan JQ; Xu XH
Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(21):1506-9. PubMed ID: 17785094
[TBL] [Abstract][Full Text] [Related]
20. MiR-100 resensitizes docetaxel-resistant human lung adenocarcinoma cells (SPC-A1) to docetaxel by targeting Plk1.
Feng B; Wang R; Chen LB
Cancer Lett; 2012 Apr; 317(2):184-91. PubMed ID: 22120675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]